Author:
Meurer William J.,Legocki Laurie,Mawocha Samkeliso,Frederiksen Shirley M.,Guetterman Timothy C.,Barsan William,Lewis Roger,Berry Donald,Fetters Michael
Funder
NIH Office of the Director
U.S. Food and Drug Administration
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference30 articles.
1. Meurer WJ, Lewis RJ, Tagle D, Fetters MD, Legocki L, et al. An overview of the Adaptive Designs Accelerating Promising Trials Into Treatments (ADAPT-IT) project. Ann Emerg Med. 2012;60:451–7.
2. Chow S-C, Chang M. Adaptive design methods in clinical trials — a review. Orphanet J Rare Dis. 2008;3:11–1.
3. Food and Drug Administration. Guidance for industry: adaptive design clinical trials for drugs and biologics. 2010.
http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM201790.pdf
. Accessed 25 Apr 2010.
4. Gallo P, Chuang-Stein C, Dragalin V, Gaydos B, Krams M, et al. Adaptive designs in clinical drug development — an executive summary of the PhRMA Working Group. J Biopharm Stat. 2006;16:275–83. discussion 285–91, 293–8, 311–2.
5. Hung HMJ, O’Neill RT, Wang S-J, Lawrence J. A regulatory view on adaptive/flexible clinical trial design. Biom J. 2006;48:565–73.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献